TNF and inflammatory bowel disease: Treatment of IBD includes untargeted therapies (e.g., amino-salicylates and glucocorticoids) and targeted biologics (e.g., anti-tumor necrosis factor antibodies), signaling inhibitors (e.g., Janus kinase inhibitors), or lymphocyte trafficking modulators (e.g., anti-α4β7 integrin antibodies).